
Opinion|Videos|February 28, 2025
The Value Proposition: Justifying the Investment in HS Centers of Excellence
Author(s)Jennifer Hsiao, MD
Panelist discusses how organizations can justify the cost of Centers of Excellence for HS by improving patient outcomes, reducing complications, and enhancing care efficiency. Metrics for evaluating multidisciplinary care include patient satisfaction, quality of life, clinical improvements, and reduction in hospitalizations.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How can organizations justify the effort/cost of establishing Centers of Excellence for HS?
- What metrics should be used to evaluate the effectiveness of multidisciplinary care in improving outcomes for HS patients?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
2
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
3
Amid SOHO Data, Reviewers of BTK Inhibitors in MCL Call for Trials
4
MFN Drug Agreements Could Raise Prices Worldwide
5







